UnitedHealth Group Incorporated (UNH)
Cash ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 25,312,000 | 25,427,000 | 23,365,000 | 21,375,000 | 16,921,000 |
Short-term investments | US$ in thousands | 3,801,000 | 4,201,000 | 4,546,000 | 2,532,000 | 2,860,000 |
Total current liabilities | US$ in thousands | 103,769,000 | 99,054,000 | 89,237,000 | 78,292,000 | 72,420,000 |
Cash ratio | 0.28 | 0.30 | 0.31 | 0.31 | 0.27 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($25,312,000K
+ $3,801,000K)
÷ $103,769,000K
= 0.28
The cash ratio of UnitedHealth Group Incorporated has shown a relatively stable trend over the past five years. The company's cash ratio increased slightly from 0.27 in December 2020 to 0.31 in December 2021 and remained steady at 0.31 in December 2022. Subsequently, there was a minor decline to 0.30 in December 2023, followed by a further decrease to 0.28 by December 2024.
The cash ratio indicates the proportion of a company's current assets held in cash or cash equivalents to cover its current liabilities. A higher cash ratio typically suggests a company has a stronger ability to cover its short-term obligations. Although UnitedHealth Group maintained a relatively healthy cash ratio above 0.25 throughout the period, the slight downward trend from 2023 to 2024 may warrant further analysis to assess the company's liquidity position and any potential impact on its financial stability.
Peer comparison
Dec 31, 2024